Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hypokinesia/fatigue

リンクがクリップボードに保存されます
ページ 1 から 37 結果

Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Parkinson's disease (PD) is a neurodegenerative multisystem disorder characterized by progressive motor symptoms such as bradykinesia, tremor and muscle rigidity. Over the course of the disease, numerous non-motor symptoms, sometimes preceding the onset of motor symptoms, significantly impair

Development of chylothorax and chylous ascites in a patient with congestive heart failure.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Chylothorax and chylous ascites are very rare clinical entities generally caused by obstruction and disruption of the thoracic duct. A 60-year-old man presented with exertional dyspnea, fatigue, and chest discomfort of 18-month history. Physical examination revealed S4, bilateral pretibial edema,

[Ergoreflex: the essence and mechanisms].

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Physical loading raises the sympathetic nervous activity which results in increased minute volume, constriction of peripheral vessels, and elevated blood pressure. These reactions are an outcome of two mechanisms: 1) the central command from cerebral structures that trigger voluntary movements to

Correlative factors of cognitive dysfunction in PD patients: a cross-sectional study from Southwest China.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND Cognitive dysfunction is common in Parkinson's disease (PD). A comprehensive understanding of cognitive dysfunction and its correlative factors in Chinese PD patients were not available. METHODS This cross-sectional study included 454 PD patients. Cognitive function was evaluated using

Psychological Stress Phenocopies Brain Mitochondrial Dysfunction and Motor Deficits as Observed in a Parkinsonian Rat Model.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Psychological distress is a public health issue as it contributes to the development of human diseases including neuropathologies. Parkinson's disease (PD), a chronic, progressive neurodegenerative disorder, is caused by multiple factors including aging, mitochondrial dysfunction, and/or stressors.

Problem based review: a patient with Parkinson's disease.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Parkinson's disease (PD) is a chronic, progressive neurodegenerative disease characterized by bradykinesia, tremor and/ or rigidity, often with gait disturbance and postural instability. In addition to these typical features, patients with PD may experience further problems related to the disease

Psychogenic parkinsonism: clinical spectrum and diagnosis.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND Patients with psychogenic parkinsonism (PP), like those with Parkinson's disease (PD), may have tremor, bradykinesia, rigidity, and gait disturbances. Unusual features predominate in PP, but clear psychogenic signs may not be obvious. Because PP may be difficult to diagnose, identifying a

Clinical Presentation of Anxiety in Parkinson's Disease: A Scoping Review.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Up to 40% of all individuals with Parkinson's disease (PD) are estimated to experience anxiety that interferes with daily functioning. This article describes research regarding the presentation of anxiety in PD and the influence anxiety has on participation in this population. A scoping review

Anesthetic experience of pheochromocytoma resection with catecholamine-induced cardiomyopathy and congestive heart failure : A case report.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Catecholamine-induced cardiomyopathy associated with pheochromocytoma is a relatively well-recognized but rare entity. We report a case of 15-year old man with a pheochromocytoma and severe heart failure caused by a catecholamine-induced cardiomyopathy. He had symptoms such as fatigue, cold

The Effects of Below Knee Compression Garments on Functional Performance in Individuals with Parkinson Disease.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
BACKGROUND Symptoms of Parkinson's disease (PD) include bradykinesia, gait abnormalities, balance deficits, restless leg syndrome, and muscular fatigue. Compression garments (CG) have been shown to improve performance in athletes by increasing venous return and reduce lactic acid. OBJECTIVE Assess

Parkinson's disease awareness.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
The main features of Parkinson's disease are tremor, bradykinesia, rigidity and postural instability. Patients also often develop other symptoms such as depression, anxiety, reduced cognitive function, sleep disturbances and fatigue. Initially, patients are well treated with levodopa, but after five

[Headache caused by pesticides--a review of the literature].

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Headache makes one of the most common side effects of frequently pesticide application. This is to be taken care of in rural areas. Headaches have been reported with the use of ivermectin, ivermectin-diethylcarbamazine, organophosphates, and also with the fungicide maneb and copper sulfate,

[A case report of severe urinary retention and meteorism during flunarizine administration].

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
A case of flunarizine hydrochloride (FZ)-induced severe urinary retention and meteorism which resulted from sphincter spasm of the urinary bladder and the anus is presented. An 81-year-old female had received 10 mg/day FZ orally for 12 months before hypokinesia and general fatigue developed.

[Scans without Evidence of Dopamine Deficit (SWEDDs)].

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Dopamine transporter (DaT) single-photon emission computed tomography (SPECT) and [18F]fluoro-L-DOPA ([18F]DOPA) positron emission tomography (PET) facilitate the investigation of dopaminergic hypofunction in neurodegenerative diseases. DaT SPECT and [18F]DOPA PET have been adopted as survey tools

Methylphenidate : a treatment for Parkinson's disease?

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Parkinson's disease (PD) affects about 1 % of the population over the age of 60 years and is characterized by a combination of rest tremor, bradykinesia, rigidity, postural instability, stooped posture and freezing of gait (FoG). However, the clinical spectrum also spans a wide range of non-motor
Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge